Projects per year
Personal profile
Education
- 1989-1991 Ph.D., Clinical Pharmacology, Imperial College, London, U.K.
- 1975-1982 M.D., School of Medicine, Taipei Medical College
Experience
- 2019.08- Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2019.08- Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2018.04- Dean, College of Medicine, Taipei Medical University
- 2018.08- Professor, Internarional Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2018.08-2024.02 Director, Research Center of Thoracic Medicine, Taipei Medical University
- 2017.08-2018.03 Professor, School of Medicine, Chang Gung University
- 2011.07-2018.03 Director of Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei
- 2009-2011 Vice Director of Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei
- 2003.07-2010.06 Director, Department of Thoracic Medicine, Chang-Gung Memorial Hospital, Taipei
- 2001.08-2018.03 Professor, School of Respiratory Therapy, Taipei Medical University
- 1995.07-2003.06 Chief of the Second Division of Chest Medicine, Department of Internal Medicine, Chang-Gung Memorial Hospital, Taipei
- 1993.08-2001.07 Associate Professor, School of Medicine, Chang Gung University
- 1989- Attending physician, Division of Chest Medicine, Department of Internal Medicine, Chang-Gung Memorial Hospital, Taipei
- 1987-1989 Fellowship, Division of Chest Medicine, Department of Internal Medicine, Chang-Gung Memorial Hospital, Taipei
- 1983-1987 Residentship, Department of Internal Medicine, Chang-Gung Memorial Hospital, Taipei
- 1980-1981 Internship, McKay Memorial Hospital, Taipei
Awards
- 科技部傑出研究獎
- 國科會傑出學者獎勵
- 國科會傑出研究獎
Research Interests
- Pulmonary Physiology
- Pulmonary Medicine & Critical Care medicine
- Cell Biology
- Lung Cancer
- Interventional bronchoscopy
Fingerprint
Dive into the research topics where Han-Pin Kuo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Serpin B III Implicated in Il-6 Trans Signaling Induced Airway Epithelial Dysfunction in Asthmatics
Kuo, H.-P. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Serpin B III Implicated in Il-6 Trans Signaling Induced Airway Epithelial Dysfunction in Asthmatics
Kuo, H.-P. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Clinical Relevance and Regulatory Mechanisms for Circulating Fibrocytes as a Novel Cellular Source of Type 2 Cytokines in Severe Asthma( III )
Kuo, H.-P. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Clinical Relevance and Regulatory Mechanisms for Circulating Fibrocytes as a Novel Cellular Source of Type 2 Cytokines in Severe Asthma( II )
Kuo, H.-P. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Clinical Relevance and Regulatory Mechanisms for Circulating Fibrocytes as a Novel Cellular Source of Type 2 Cytokines in Severe Asthma( I )
Kuo, H.-P. (PI)
8/1/20 → 7/31/21
Project: A - Government Institution › b - National Science and Technology Council
-
Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells
Hsieh, T. H., Kuo, H. P., Chen, M. C., Lin, Y. C., Lin, B. J., Hsu, K. C. & Chen, C. H., Dec 2025, In: Scientific Reports. 15, 1, 20922.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer
NeoADAURA Investigators, Sept 10 2025, In: Journal of Clinical Oncology. 43, 26, p. 2875-2887 13 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Citations (Scopus) -
Personalized serum proteome profiles of COVID-19-associated acute respiratory distress syndrome in response to mesenchymal stem cell therapy
Putri, D. U., Chen, M. C., Weng, C. M., Kuo, H. P., Lee, C. H. & Han, C. L., 2025, In: Journal of Microbiology, Immunology and Infection.Research output: Contribution to journal › Article › peer-review
Open Access -
IL-33/ST2 axis mediates diesel exhaust particles-induced mast cell activation
Cheng, W. H., Zhuang, T. L., Lee, M. J., Chou, C. L., Chen, B. C., Kuo, H. P. & Weng, C. M., Dec 2024, In: Molecular Medicine. 30, 1, 262.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma
Weng, C. M., Wu, W. C., Lee, M. J., Chen, M. C., Chou, C. L., Lin, C. Y., Chung, K. F. & Kuo, H. P., Mar 2024, In: Respirology. 29, 3, p. 252-255 4 p.Research output: Contribution to journal › Letter › peer-review
1 Citation (Scopus)